Artigo Acesso aberto Revisado por pares

Percutaneous Heart Valve in the Chronic In Vitro Testing Model

2002; Lippincott Williams & Wilkins; Volume: 106; Issue: 12 Linguagem: Inglês

10.1161/01.cir.0000033308.01553.2b

ISSN

1524-4539

Autores

David Paniagua, Eduardo Induni, Carolyne Ortiz, Carlos Mejia, Francisco López-Jiménez, R. David Fish,

Tópico(s)

Cardiomyopathy and Myosin Studies

Resumo

HomeCirculationVol. 106, No. 12Percutaneous Heart Valve in the Chronic In Vitro Testing Model Free AccessReview ArticlePDF/EPUBAboutView PDFView EPUBSections ToolsAdd to favoritesDownload citationsTrack citationsPermissionsDownload Articles + Supplements ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toSupplementary MaterialsFree AccessReview ArticlePDF/EPUBPercutaneous Heart Valve in the Chronic In Vitro Testing Model David Paniagua, MD, Eduardo Induni, MD, Carolyne Ortiz, BSc, Carlos Mejia, BA, Francisco Lopez-Jimenez, MD and R. David Fish, MD David PaniaguaDavid Paniagua From the Baptist Hospital and Biomedical Engineer Florida International University and Kendal Medical Center, Miami, Fla (D.P.); Hospital Mexico and University of Costa Rica, San Jose, Costa Rica (E.I., C.O.); Mayo Clinic, Rochester, Minn (F.L.-J.); St Luke's Episcopal Hospital/Texas Heart Institute and Baylor College of Medicine and University of Texas, Houston (R.D.F.); and Endoluminal Technology Research, Miami, Fla (C.M.). , Eduardo InduniEduardo Induni From the Baptist Hospital and Biomedical Engineer Florida International University and Kendal Medical Center, Miami, Fla (D.P.); Hospital Mexico and University of Costa Rica, San Jose, Costa Rica (E.I., C.O.); Mayo Clinic, Rochester, Minn (F.L.-J.); St Luke's Episcopal Hospital/Texas Heart Institute and Baylor College of Medicine and University of Texas, Houston (R.D.F.); and Endoluminal Technology Research, Miami, Fla (C.M.). , Carolyne OrtizCarolyne Ortiz From the Baptist Hospital and Biomedical Engineer Florida International University and Kendal Medical Center, Miami, Fla (D.P.); Hospital Mexico and University of Costa Rica, San Jose, Costa Rica (E.I., C.O.); Mayo Clinic, Rochester, Minn (F.L.-J.); St Luke's Episcopal Hospital/Texas Heart Institute and Baylor College of Medicine and University of Texas, Houston (R.D.F.); and Endoluminal Technology Research, Miami, Fla (C.M.). , Carlos MejiaCarlos Mejia From the Baptist Hospital and Biomedical Engineer Florida International University and Kendal Medical Center, Miami, Fla (D.P.); Hospital Mexico and University of Costa Rica, San Jose, Costa Rica (E.I., C.O.); Mayo Clinic, Rochester, Minn (F.L.-J.); St Luke's Episcopal Hospital/Texas Heart Institute and Baylor College of Medicine and University of Texas, Houston (R.D.F.); and Endoluminal Technology Research, Miami, Fla (C.M.). , Francisco Lopez-JimenezFrancisco Lopez-Jimenez From the Baptist Hospital and Biomedical Engineer Florida International University and Kendal Medical Center, Miami, Fla (D.P.); Hospital Mexico and University of Costa Rica, San Jose, Costa Rica (E.I., C.O.); Mayo Clinic, Rochester, Minn (F.L.-J.); St Luke's Episcopal Hospital/Texas Heart Institute and Baylor College of Medicine and University of Texas, Houston (R.D.F.); and Endoluminal Technology Research, Miami, Fla (C.M.). and R. David FishR. David Fish From the Baptist Hospital and Biomedical Engineer Florida International University and Kendal Medical Center, Miami, Fla (D.P.); Hospital Mexico and University of Costa Rica, San Jose, Costa Rica (E.I., C.O.); Mayo Clinic, Rochester, Minn (F.L.-J.); St Luke's Episcopal Hospital/Texas Heart Institute and Baylor College of Medicine and University of Texas, Houston (R.D.F.); and Endoluminal Technology Research, Miami, Fla (C.M.). Originally published17 Sep 2002https://doi.org/10.1161/01.CIR.0000033308.01553.2BCirculation. 2002;106:e51–e52The endeavor to create a percutaneous aortic valve dates back to 1965. Several researchers have tried to develop this project since that time. Our group started working on the development of a percutaneous heart valve for human use in early 1998.We implanted the first percutaneous heart valve in animals in June of 2000 in Costa Rica. We have tested this newly designed valve for almost 2 years in a chronic in vitro testing model that consists of a closed circuit of plastic tubing connected to a reservoir and a pulsatile diaphragmatic pump (flow rates from 1 to 5 gallons per minute) that mimics the heart function. The liquid used is water combined with 30% glycerol to have the same viscosity of blood. The percutaneous valve is placed at the bottom of the 2600-mm water-glycerol column to be subject to a diastolic pressure of ≈200 mm Hg.We have noticed no sign of deterioration and excellent hemodynamic profile. The valve is shown in the closed (Figures 1 and 2) and opened (Figure 3) positions. The opening and closing of the valve is clearly seen in Movie I. A two-dimensional ultrasound of the valve is shown in Movie II. Download figureDownload PowerPointFigure 1. Leaflets of a percutaneous aortic valve in the closing position seen from the aortic side.Download figureDownload PowerPointFigure 2. Leaflets of the percutaneous aortic valve in the closing position seen from the ventricular side.Download figureDownload PowerPointFigure 3. Leaflets of the percutaneous aortic valve in the partially opened position seen from the aortic side.Movies I and II are available in an online-only Data Supplement at http://www.circulationaha.org.The editor of Images in Cardiovascular Medicine is Hugh A. McAllister, Jr, MD, Chief, Department of Pathology, St Luke's Episcopal Hospital and Texas Heart Institute, and Clinical Professor of Pathology, University of Texas Medical School and Baylor College of Medicine.Circulation encourages readers to submit cardiovascular images to the Circulation Editorial Office, St Luke's Episcopal Hospital/Texas Heart Institute, 6720 Bertner Ave, MC1-267, Houston, TX 77030.FootnotesCorrespondence to David Paniagua, MD, 1865 79 St Causeway, Suite 7H, Miami Beach, FL 33141. E-mail [email protected] Previous Back to top Next FiguresReferencesRelatedDetailsCited By Boskovski M, Nguyen T, McCabe J and Kaneko T (2020) Outcomes of Transcatheter Aortic Valve Replacement in Patients With Severe Aortic Stenosis, JAMA Surgery, 10.1001/jamasurg.2019.4449, 155:1, (69), Online publication date: 1-Jan-2020. Bourantas C and Serruys P (2014) Evolution of Transcatheter Aortic Valve Replacement, Circulation Research, 114:6, (1037-1051), Online publication date: 14-Mar-2014. Rozeik M, Wheatley D and Gourlay T (2014) Percutaneous heart valves; past, present and future, Perfusion, 10.1177/0267659114523464, 29:5, (397-410), Online publication date: 1-Sep-2014. Gujral D and Bhattacharyya S (2013) Cardiac manifestations of gastrointestinal carcinoid tumor, Future Cardiology, 10.2217/fca.13.24, 9:4, (479-488), Online publication date: 1-Jul-2013. Askew J and Connolly H (2013) Carcinoid Valve Disease, Current Treatment Options in Cardiovascular Medicine, 10.1007/s11936-013-0265-2, 15:5, (544-555), Online publication date: 1-Oct-2013. Bateman M and Iaizzo P (2011) Comparative imaging of cardiac structures and function for the optimization of transcatheter approaches for valvular and structural heart disease, The International Journal of Cardiovascular Imaging, 10.1007/s10554-011-9807-4, 27:8, (1223-1234), Online publication date: 1-Dec-2011. Pati A, Ladipo K, Paniagua D and Glowinski R (2011) Three dimensional fluid–structure interaction under pulsatile flow by using distributed Lagrange multiplier method, Mathematical and Computer Modelling, 10.1016/j.mcm.2010.07.009, 53:1-2, (21-41), Online publication date: 1-Jan-2011. Tambača J, Kosor M, Čanić S and M.D. D (2010) Mathematical Modeling of Vascular Stents, SIAM Journal on Applied Mathematics, 10.1137/080722618, 70:6, (1922-1952), Online publication date: 1-Jan-2010. Vergnat M, Henaine R, Kalejs M, Bommeli S, Ferrari E, Obadia J and Von Segesser L (2009) A new self-expanding aortic stent valve with annular fixation: in vitro haemodynamic assessment, European Journal of Cardio-Thoracic Surgery, 10.1016/j.ejcts.2009.01.052, 35:6, (970-976), Online publication date: 1-Jun-2009. Libera P, Götz W, Schreiber C, Bauernschmitt R and Lange R (2009) Innovative Aortenklappenimplantation Medizintechnik, 10.1007/978-3-540-93936-8_61, (1403-1418), . Libera P, Götz W, Schreiber C, Bauernschmitt R and Lange R Innovative Aortenklappenimplantation Medizintechnik Life Science Engineering, 10.1007/978-3-540-74925-7_49, (1099-1114) Iaizzo P, Hill A and Laske T (2014) Cardiac device testing enhanced by simultaneous imaging modalities: the Visible Heart ® , fluoroscopy and echocardiography , Expert Review of Medical Devices, 10.1586/17434440.5.1.51, 5:1, (51-58), Online publication date: 1-Jan-2008. Flecher E, Curry J, Joudinaud T, Saber H, MacNett J, Ahlin A, Weber P and Duran C (2008) In Vitro Study of Percutaneous Aortic Valve Replacement: Selection of a Tissue Valve, Journal of Cardiac Surgery, 10.1111/j.1540-8191.2008.00593.x, 23:3, (234-238), Online publication date: 1-May-2008. Bhattacharyya S, Davar J, Dreyfus G and Caplin M (2007) Carcinoid Heart Disease, Circulation, 10.1161/CIRCULATIONAHA.107.701367, 116:24, (2860-2865), Online publication date: 11-Dec-2007. Davidson M, White J and Baim D (2006) Percutaneous therapies for valvular heart disease, Cardiovascular Pathology, 10.1016/j.carpath.2006.02.004, 15:3, (123-129), Online publication date: 1-May-2006. Šochman J, Peregrin J, Roček M, Timmermans H, Pavcnik D and Rösch J (2005) Percutaneous Transcatheter One-Step Mechanical Aortic Disc Valve Prosthesis Implantation: A Preliminary Feasibility Study in Swine, CardioVascular and Interventional Radiology, 10.1007/s00270-005-0029-9, 29:1, (114-119), Online publication date: 1-Feb-2006. Ruiz C (2005) Transcatheter Aortic Valve Implantation and Mitral Valve Repair: State of the Art, Pediatric Cardiology, 10.1007/s00246-004-0963-3, 26:3, (289-294), Online publication date: 1-Jun-2005. Vahanian A and Palacios I (2004) Percutaneous Approaches to Valvular Disease, Circulation, 109:13, (1572-1579), Online publication date: 6-Apr-2004.Fish R (2004) Percutaneous Heart Valve Replacement, Circulation, 110:14, (1876-1878), Online publication date: 5-Oct-2004. Webb J, Munt B, Makkar R, Naqvi T and Dang N (2004) Percutaneous stent-mounted valve for treatment of aortic or pulmonary valve disease, Catheterization and Cardiovascular Interventions, 10.1002/ccd.20112, 63:1, (89-93), Online publication date: 1-Sep-2004. Maisch B and Christ M (2004) Extrakardiale Ursachen der RechtsherzinsuffizienzExtracardiac causes of right ventricular insufficiency, Der Internist, 10.1007/s00108-004-1280-x, 45:10, (1136-1146), Online publication date: 1-Oct-2004. Levi D, Alejos J and Moore J (2003) Future of interventional cardiology in pediatrics, Current Opinion in Cardiology, 10.1097/00001573-200303000-00002, 18:2, (79-90), Online publication date: 1-Mar-2003. Burke R and White J (2003) Achieving resonance in a congenital heart team, Progress in Pediatric Cardiology, 10.1016/S1058-9813(03)00079-1, 18:1, (65-73), Online publication date: 1-Nov-2003. September 17, 2002Vol 106, Issue 12 Advertisement Article InformationMetrics https://doi.org/10.1161/01.CIR.0000033308.01553.2BPMID: 12234968 Originally publishedSeptember 17, 2002 PDF download Advertisement

Referência(s)
Altmetric
PlumX